MICA and hepatocellular carcinoma: For instance, reduced expression of the major histocompatibility complex class I chain-related protein A and B (MICA/B), the ligand of the NKG2D activating receptor, is associated with a significantly shorter disease-free and overall survival in patients with HCC compared with patients with preserved MICA expression [32,33].